Latest reported quarter: Q2, ended Jun 2026
Quarter 2026/Q2
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $1.18B | $841.83M | $3.66B | $866.29M | $971.85M |
| Total Operating Revenue | $1.18B | $841.83M | $3.66B | $866.29M | $971.85M |
| Cost of Revenue | $1.07B | $744.21M | $3.26B | $759.16M | $867.08M |
| Gross Profit | $112.79M | $97.62M | $402.71M | $107.13M | $104.77M |
| Operating Expense | $78.60M | $79.99M | $349.29M | $84.51M | $84.07M |
| Selling and Admin Expenses | $11.30M | $11.05M | $46.69M | $11.97M | $11.23M |
| -General & Admin Expense | $11.30M | $11.05M | $46.69M | $11.97M | $11.23M |
| Depreciation & Amortization & Depletion | $16.77M | $17.06M | $89.59M | $19.92M | $20.03M |
| -Depreciation & Amortization | $16.77M | $17.06M | $89.59M | $19.92M | $20.03M |
| Other Operating Expenses | $50.53M | $51.88M | $213.01M | $52.62M | $52.81M |
| Operating Profit | $34.19M | $17.63M | $53.42M | $22.62M | $20.70M |
| Net Non-Operating Interest Income (Expense) | -$11.34M | -$10.75M | -$48.14M | -$10.94M | -$11.79M |
| Non-Operating Interest Expense | $11.34M | $10.75M | $48.14M | $10.94M | $11.79M |
| Other Income (Expense) | $1.30M | $6.27M | $44.81M | $3.60M | $7.54M |
| Special Income (Charges) | $1.09M | $6.12M | $44.23M | $3.44M | $7.39M |
| -Less:Other Special Charges | -$1.09M | -$6.12M | -$44.23M | -$3.44M | -$7.39M |
| Other Non-Operating Income (Expenses) | $212,000.00 | $157,000.00 | $577,000.00 | $159,000.00 | $152,000.00 |
| Pretax Profit | $24.14M | $13.16M | $50.09M | $15.28M | $16.45M |
| Tax | $3.33M | $2.50M | $8.25M | $5.09M | $2.87M |
| Net Profit | $20.81M | $10.66M | $41.83M | $10.19M | $13.59M |
| Profit from Continuing Operations | $20.81M | $10.66M | $41.83M | $10.19M | $13.59M |
| Net Income to Parent Company | $20.81M | $9.97M | $39.11M | $7.47M | $13.59M |
| Other Preferred Stock Dividends | $710,000.00 | – | – | – | $696,000.00 |
| Net Income to Common Stockholders | $20.10M | $9.97M | $39.11M | $9.51M | $12.89M |
| Basic EPS | $0.53 | $0.26 | $1.03 | $0.25 | $0.34 |
| Diluted EPS | $0.52 | $0.26 | $1.02 | $0.25 | $0.34 |
| Dividend Per Share | $0.53 | $0.53 | $2.10 | $0.53 | $0.53 |
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Total Assets | $981.99M | $1.00B | $964.73M | $964.73M | $998.94M |
| Total Current Assets | $122.76M | $125.27M | $111.08M | $111.08M | $117.36M |
| Cash and Cash Equivalents & Short-Term Investments | $4.92M | $7.35M | $3.14M | $3.14M | $5.77M |
| -Cash and Cash Equivalents | $4.92M | $7.35M | $3.14M | $3.14M | $5.77M |
| Receivables | $34.49M | $31.94M | $29.25M | $29.25M | $34.57M |
| -Accounts Receivable | $33.83M | $31.14M | $28.57M | $28.57M | $34.06M |
| -Due from Related Parties Current | $651,000.00 | $805,000.00 | $687,000.00 | $687,000.00 | $514,000.00 |
| Inventory | $63.44M | $65.06M | $59.61M | $59.61M | $60.97M |
| Other Current Assets | $7.87M | $11.68M | $8.59M | $8.59M | $8.52M |
| Total Non-Current Assets | $859.22M | $877.53M | $853.65M | $853.65M | $881.58M |
| Net PPE | $680.94M | $697.01M | $669.32M | $669.32M | $693.57M |
| -Gross PPE | $1.08B | $1.09B | $1.08B | $1.08B | $1.10B |
| -Accumulated Depreciation | -$398.26M | -$389.23M | -$413.01M | -$413.01M | -$407.45M |
| Financial Assets | $1.86M | $1.08M | $325,000.00 | $325,000.00 | $325,000.00 |
| Goodwill and Other Intangible Assets | $153.82M | $157.40M | $161.05M | $161.05M | $164.50M |
| -Goodwill | $99.41M | $99.41M | $99.41M | $99.41M | $99.41M |
| -Other Intangible Assets | $54.41M | $57.99M | $61.64M | $61.64M | $65.10M |
| Non-Current Deferred Assets | $0.00 | $555,000.00 | $760,000.00 | $760,000.00 | $1.38M |
| Other Non-Current Assets | $22.61M | $21.49M | $22.20M | $22.20M | $21.80M |
| Total Liabilities | $1.09B | $1.11B | $1.07B | $1.07B | $1.09B |
| Total Current Liabilities | $161.83M | $167.91M | $155.22M | $155.22M | $164.21M |
| Payables | $101.93M | $103.74M | $104.82M | $104.82M | $97.41M |
| -Accounts Payable | $77.73M | $77.40M | $63.41M | $63.41M | $71.72M |
| -Total Tax Payable | $16.41M | $19.15M | $33.07M | $33.07M | $18.63M |
| -Due to Related Parties Current | $7.79M | $7.19M | $6.54M | $6.54M | $7.06M |
| Current Accrued Expenses | $25.36M | $28.60M | $3.03M | $3.03M | $28.71M |
| Short-Term Debt and Capital Lease Obligation | $34.36M | $35.14M | $38.18M | $38.18M | $37.62M |
| -Current Capital Lease Obligation | $34.36M | $35.14M | $38.18M | $38.18M | $34.21M |
| Other Current Liabilities | $184,000.00 | $431,000.00 | $4.45M | $4.45M | $480,000.00 |
| Total Non-Current Liabilities | $927.36M | $944.33M | $911.85M | $911.85M | $926.45M |
| Long Term Debt and Capital Lease Obligation | $796.15M | $812.35M | $778.45M | $778.45M | $795.70M |
| -Long Term Debt | $666.27M | $676.19M | $686.00M | $686.00M | $700.79M |
| -Long Term Capital Lease Obligation | $129.89M | $136.16M | $92.46M | $92.46M | $94.91M |
| Derivative Product Liabilities | $109,000.00 | $517,000.00 | $1.39M | $1.39M | $1.84M |
| Non-Current Liabilities | $44.22M | $44.65M | $52.40M | $52.40M | $45.24M |
| Non-Current Deferred Liabilities | $7.48M | $7.19M | $29.55M | $29.55M | $5.27M |
| Convertible preferred securities | $31.52M | $30.98M | $30.29M | $30.29M | $29.77M |
| Other Non-Current Liabilities | $47.88M | $48.64M | $19.76M | $19.76M | $48.63M |
| Total Equity | -$107.20M | -$109.43M | -$102.33M | -$102.33M | -$91.73M |
| Share capital | -$107.20M | -$109.43M | -$102.33M | -$102.33M | -$91.73M |
| -Other Payable | – | – | $1.80M | $1.80M | – |
| Current Provisions | – | – | $2.30M | $2.30M | – |
| Long Term Accounts Payable and Other Payables | – | – | $0.00 | $0.00 | – |
| -Current Debt | – | – | – | – | $3.41M |
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Operating Cash Flow | $33.23M | $27.88M | $91.50M | $29.43M | $24.37M |
| Net cash flow from continuing operations | $33.23M | $27.88M | $91.50M | $29.43M | $24.37M |
| Net Income from Continuing Operations | $20.81M | $10.66M | $41.83M | $10.19M | $13.59M |
| Gain/Loss from Continuing Operations | -$1.09M | -$6.12M | -$44.23M | -$3.44M | -$7.39M |
| Depreciation & Depletion & Amortization | $16.77M | $17.06M | $89.59M | $19.92M | $20.03M |
| Deferred Tax | $841,000.00 | -$11,000.00 | -$161,000.00 | $2.76M | -$222,000.00 |
| Other Non-Cash Items | $484,000.00 | $484,000.00 | $1.94M | $486,000.00 | $484,000.00 |
| Change in Working Capital | -$5.18M | $5.57M | $673,000.00 | -$981,000.00 | -$2.49M |
| -Change in Receivables | -$2.53M | -$2.72M | $2.83M | $5.27M | -$1.99M |
| -Change in Inventory | $1.55M | -$5.45M | $1.74M | $1.36M | -$2.04M |
| -Change in Payables and Accrued Expense | -$5.60M | $15.46M | -$4.25M | -$8.44M | $2.08M |
| -Change in Other Current Assets | $3.05M | -$2.07M | -$1.67M | $89,000.00 | -$1.41M |
| -Change in Other Current Liabilities | -$1.66M | $354,000.00 | $2.02M | $747,000.00 | $866,000.00 |
| Net cash flow from investing | -$4.14M | $7.84M | $68.44M | $2.22M | $15.35M |
| Net Cash Flow from Continuing Investing Activities | -$4.14M | $7.84M | $68.44M | $2.22M | $15.35M |
| Capital Expenditure | -$7.45M | -$3.43M | -$35.73M | -$7.07M | -$6.70M |
| Net Business Purchase and Sale | $0.00 | -$1.80M | – | – | – |
| Net Other Investing Changes | $3.31M | $13.07M | $104.17M | $9.29M | $22.05M |
| Financing Cash Flow | -$31.52M | -$31.51M | -$160.18M | -$34.28M | -$43.67M |
| Net Cash Flow from Continuing Financing Activities | -$31.52M | -$31.51M | -$160.18M | -$34.28M | -$43.67M |
| Net Issuance Payments Of Debt | -$11.25M | -$11.42M | -$78.47M | -$14.04M | -$22.33M |
| Cash Dividends Paid | -$20.03M | -$20.02M | -$80.01M | -$20.01M | -$20.01M |
| Net Other Financing Charges | -$70,000.00 | -$69,000.00 | -$1.71M | -$229,000.00 | -$1.33M |
| Ending Cash Balance | $4.92M | $7.35M | $3.14M | $3.14M | $5.77M |
| Net Change in Cash | -$2.43M | $4.21M | -$244,000.00 | -$2.63M | -$3.95M |
| Beginning Cash Balance | $7.35M | $3.14M | $3.38M | $5.77M | $9.72M |
| Free Cash Flow | $25.78M | $24.45M | $55.77M | $22.36M | $17.67M |
No comments yet — be the first to weigh in on CAPL.